Author

Wenbin Shen

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Lymph Node Regression Improves Prognostic Stratification in Esophageal Squamous Cell Carcinoma Receiving Neoadjuvant Chemoimmunotherapy: A Multicenter Retrospective Cohort Study

ABSTRACT Lymph nodes (LNs), principal sites of antitumor immunity, may undergo immune‐mediated regression; whether neoadjuvant chemoimmunotherapy (NCIT)‐induced regression indicates prognosis in esophageal squamous cell carcinoma (ESCC) remains unclear. We aimed to establish and validate a lymph node regression grade (...

Jian Zheng, Wen-Bin Shen, J. Cao et al. · MedComm · 0 citations

Open access Aug 2026

A real-world multicenter study on postoperative adjuvant treatment patterns and prognostic implications following neoadjuvant immunochemotherapy for esophageal squamous cell carcinoma

For ESCC patients receiving nICT, postoperative adjuvant treatment can provide survival benefits, particularly more pronounced in non-pCR patients and those with advanced postoperative pathological stages, particularly more pronounced in non-pCR patients and those with advanced postoperative pathological stages.

Xue-Yuan Zhang, Hong-Mei Gao, J. Cao et al. · Frontiers in Immunology · 0 citations